News

Press ReleaseNetwork established to identify opportunities for regulation to support innovation within advanced therapies
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Challenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processChallenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesRegulatory Round-up - September 2023Regulatory Round-up - September 2023Risky Business: How to de-risk your ATMP asset to attract investmentRisky Business: How to de-risk your ATMP asset to attract investmentCollaboration recommends how to improve patient referral pathways for gene therapiesCollaboration recommends how to improve patient referral pathways for gene therapiesCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandSelecting appropriate models for non-clinical studies of gene therapiesSelecting appropriate models for non-clinical studies of gene therapiesRegulatory Round-up - August 2023Regulatory Round-up - August 2023Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Regulatory Round-up - July 2023